ZNF564 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.679750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.586000E-01
Normal-vs-Stage2
8.823500E-03
Normal-vs-Stage3
7.232300E-02
Normal-vs-Stage4
2.150400E-01
Stage1-vs-Stage2
1.313150E-01
Stage1-vs-Stage3
7.630100E-02
Stage1-vs-Stage4
4.607000E-01
Stage2-vs-Stage3
1.806820E-01
Stage2-vs-Stage4
8.194400E-01
Stage3-vs-Stage4
2.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.087800E-02
Normal-vs-AfricanAmerican
7.380000E-02
Normal-vs-Asian
7.174100E-02
Caucasian-vs-AfricanAmerican
5.987400E-01
Caucasian-vs-Asian
8.209400E-01
AfricanAmerican-vs-Asian
4.860800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.927500E-02
Normal-vs-Female
1.169890E-02
Male-vs-Female
8.049200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.074200E-01
Normal-vs-Age(41-60Yrs)
3.863800E-02
Normal-vs-Age(61-80Yrs)
1.494260E-02
Normal-vs-Age(81-100Yrs)
2.682800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.895370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.121600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.974400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.047380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.578600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.911400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.004700E-03
Normal-vs-Daily Drinker
2.682400E-02
Normal-vs-Weekly Drinker
2.080200E-01
Normal-vs-Occasional Drinker
8.214100E-02
Normal-vs-Social Drinker
7.642300E-02
Non Drinker-vs-Daily Drinker
6.377000E-01
Non Drinker-vs-Weekly Drinker
6.640400E-01
Non Drinker-vs-Occasional Drinker
9.186500E-02
Non Drinker-vs-Social Drinker
1.332190E-01
Daily Drinker-vs-Weekly Drinker
4.101200E-01
Daily Drinker-vs-Occasional Drinker
2.577400E-01
Daily Drinker-vs-Social Drinker
3.258000E-01
Weekly Drinker-vs-Occasional Drinker
4.857900E-02
Weekly Drinker-vs-Social Drinker
6.093700E-02
Occasional Drinker-vs-Social Drinker
9.131200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.164200E-02
Normal-vs-Grade 2
5.775600E-03
Normal-vs-Grade 3
9.721000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.164800E-01
Grade 1-vs-Grade 3
3.766200E-01
Grade 1-vs-Grade 4
6.164200E-02
Grade 2-vs-Grade 3
8.337200E-01
Grade 2-vs-Grade 4
5.775600E-03
Grade 3-vs-Grade 4
9.721000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.860600E-03
Normal-vs-NonDiabetic
2.946300E-02
Diabetic-vs-NonDiabetic
9.992300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.647500E-02
Normal-vs-NoPancreatitis
1.888280E-02
Pancreatitis-vs-NoPancreatitis
6.505000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.102300E-02
Normal-vs-N1
1.002120E-02
N0-vs-N1
2.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.919400E-01
Normal-vs-TP53-NonMutant
1.638440E-01
TP53-Mutant-vs-TP53-NonMutant
5.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
